Botulinum toxin type B for treatment of spasmodic dysphonia: A case report

被引：4
作者：
Sataloff, RT
Heman-Ackah, YD
Simpson, LL
Park, JB
Zwislewski, A
Sokolow, C
Mandel, S
机构：
[1] Thomas Jefferson Univ, Div Occupat & Environm Hlth Sci, Philadelphia, PA 19107 USA
[2] Univ Penn, Grad Hosp, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA
[3] Univ Illinois, Dept Otolaryngol Head & Neck Surg, Chicago, IL USA
[4] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA
[5] Amer Inst Voice & Ear Res, Philadelphia, PA USA
来源：
JOURNAL OF VOICE | 2002年 / 16卷 / 03期
关键词：
botulinum toxin; spasmodic dysphonia; laryngeal dystonia; botulinum toxin B;
D O I：
10.1016/S0892-1997(02)00114-5
中图分类号：
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号：
100104 ; 100213 ;
摘要：
Although treatment with botulinum toxin type A (BTXA) has become the standard of care for most patients with laryngeal dystonia, its use is limited by the development of resistance to the toxin in some patients. Botulinum toxin type B (BTXB) has been found to be safe and effective in the treatment of cervical dystonia, but it has not been used previously to treat spasmodic dysphonia. Our experience with BTXB in a patient who developed resistance to BTXA suggests that BTXB may be safe and effective for the treatment of laryngeal dystonia, as well.
引用
收藏
页码：422 / 424
页数：3
相关论文
共 8 条
[1]   Botulinum toxin therapy, immunologic resistance, and problems with available materials [J].
Borodic, G ;
Johnson, E ;
Goodnough, M ;
Schantz, E .
NEUROLOGY, 1996, 46 (01) :26-29
[2]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia [J].
Brashear, A ;
Lew, MF ;
Dykstra, DD ;
Comella, CL ;
Factor, SA ;
Rodnitzky, RL ;
Trosch, R ;
Singer, C ;
Brin, MF ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1439-1446
[3]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia [J].
Brin, MF ;
Lew, MF ;
Adler, CH ;
Comella, CL ;
Factor, SA ;
Jankovic, J ;
O'Brien, C ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1431-1438
[4]   THERAPEUTIC USES OF BOTULINUM TOXIN [J].
JANKOVIC, J ;
BRIN, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1186-1194
[5]  
KING J, 1995, NEUROLOGY, V45, P2109
[6]   Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia [J].
Lew, MF ;
Adornato, BT ;
Duane, DD ;
Dykstra, DD ;
Factor, SA ;
Massey, JM ;
Brin, MF ;
Jankovic, J ;
Rodnitzky, RL ;
Singer, C ;
Swenson, MR ;
Tarsy, D ;
Murray, JJ ;
Koller, M ;
Wallace, JD .
NEUROLOGY, 1997, 49 (03) :701-707
[7]  
Neuenschwander M C, 2000, Ear Nose Throat J, V79, P788
[8]   Human response to botulinum toxin injection: Type B compared with type A [J].
Sloop, RR ;
Cole, BA ;
Escutin, RO .
NEUROLOGY, 1997, 49 (01) :189-194
1